Jean-Jacques Kiladjian

Université Paris Cité and Hôpital Saint-Louis

Paris, FR

Jean-Jacques Kiladjian is Professor of Medicine at Université Paris Cité, consultant hematologist, and Head of the Clinical Investigation Centre at Saint-Louis Hospital in Paris, France. Since 2025, he has also served as Director of the Clinical Research Department at the French National Institute of Health and Medical Research (INSERM). Professor Kiladjian’s work focuses on clinical research and the development of novel therapeutics for the treatment of patients with myeloproliferative neoplasms (MPN) and myelodysplastic syndromes.  

Professor Kiladjian is an active member of many societies, including the European Hematology Association, for which he is Co-Chair of the Specialized Working Group on MPN. He is also a member of the American Society of Hematology, as well as the European LeukemiaNet, for which he is secretary of the MPN Working Group, and President of the French Intergroup of Myeloproliferative Neoplasms. 

Registration form

Registration is free.

By registering for this symposium, you confirm that you are not an HCP practicing in the UK or USA. This content is intended solely for HCPs practicing outside these jurisdictions.

Required fields

Thank you!

You have successfully registered for the webinar.

Please check your email for further information on how to attend.

Add to Calendar - download calendar invite file